0 TSX Venture News - October 16, 2020First Patient Dosed in Phase II Trial to Treat Complications in COVID-19TORONTO, Oct. 16, 2020 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), […]Read More
0 NYSE Companies - October 16, 2020CrossAmerica Partners to Announce Third Quarter 2020 Earnings Results on November 4Allentown, Oct. 16, 2020 (GLOBE NEWSWIRE) — CrossAmerica Partners to AnnounceThird Quarter 2020 Earnings Results on November 4ALLENTOWN, PA, October […]Read More
0 NASDAQ Companies - October 16, 2020First Citizens BancShares Reports Earnings for Third Quarter 2020RALEIGH, N.C., Oct. 16, 2020 (GLOBE NEWSWIRE) — First Citizens BancShares Inc. (“BancShares”) (Nasdaq: FCNCA) reported strong earnings for the […]Read More
0 NASDAQ Companies - October 16, 2020Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)First therapy recommended for full marketing authorization in the EU for eligible patients with confirmed diagnosis of late infantile or […]Read More
0 NASDAQ Companies - October 16, 2020First Citizens BancShares, Inc. and CIT Group Inc. Announce Transformational Partnership to Create a Top-Performing Commercial BankMerger creates a Top 20 U.S. bank with over $100 billion in assetsCreates greater scale to drive growth, improve profitability […]Read More
0 TSX News - October 16, 2020McEwen Mining: Q3 2020 Production and Exploration ResultsTORONTO, Oct. 16, 2020 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) reports consolidated production for Q3 2020 […]Read More
0 NASDAQ Companies - October 16, 2020ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions— ASLAN believes ASLAN003 has the potential to be the most potent oral inhibitor of DHODH currently in development for […]Read More
0 NASDAQ Companies - October 16, 2020ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions— ASLAN believes ASLAN003 has the potential to be the most potent oral inhibitor of DHODH currently in development for […]Read More
0 NASDAQ Companies - October 16, 2020Yandex and Tinkoff Group Terminate DiscussionsTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATIONNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY […]Read More
0 Canadian Stock Exchange News - October 16, 2020“Dean of the Industry”: Ohio-Based Wholesale Distribution Icon and Former Lorillard Board Member Kit Dietz Appointed to Taat Advisory BoardLAS VEGAS and VANCOUVER, British Columbia, Oct. 16, 2020 (GLOBE NEWSWIRE) — TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: […]Read More